Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00917813
What this trial is testing

Anti-HIV Monoclonal Antibody KD-247

Who this might be right for
HIV Infections
The Chemo-Sero-Therapeutic Research Institute 27
Post-approval studies (Phase 4)Active Not RecruitingNCT06678373
What this trial is testing

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

Who this might be right for
Japanese Encephalitis
Liaoning Chengda Biotechnology CO., LTD 250
Not applicableStudy completedNCT04699903
What this trial is testing

Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood

Who this might be right for
SARS-Cov-2, Covid19
Lumos Diagnostics 201
Not applicableStudy completedNCT05195060
What this trial is testing

TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

Who this might be right for
COVID-19
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,178
Not applicableStudy completedNCT05614336
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
COVID-19Cystic Fibrosis
Hospices Civils de Lyon 331
Post-approval studies (Phase 4)Study completedNCT02798952
What this trial is testing

Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

Who this might be right for
Hepatitis B
GlaxoSmithKline 302
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Testing effectiveness (Phase 2)Ended earlyNCT00228592
What this trial is testing

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Who this might be right for
Hepatitis BLiver Transplantation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Not applicableActive Not RecruitingNCT04411147
What this trial is testing

A Longitudinal Study of COVID-19 Sequelae and Immunity

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 583
Early research (Phase 1)Active Not RecruitingNCT07053384
What this trial is testing

Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

Who this might be right for
HIV Infections
ViiV Healthcare 130
Large-scale testing (Phase 3)WithdrawnNCT05142527
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

Who this might be right for
COVID-19
Alachua Government Services, Inc.
Early research (Phase 1)Study completedNCT03408262
What this trial is testing

Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women

Who this might be right for
Human Immunodeficiency Virus
Imperial College London 68
Not applicableStudy completedNCT04383587
What this trial is testing

Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers

Who this might be right for
SARS-CoV 2COVID-19
Mayo Clinic 300
Not applicableStudy completedNCT04992234
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
Cystic FibrosisCovid19
Vastra Gotaland Region 113
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Large-scale testing (Phase 3)Study completedNCT04805125
What this trial is testing

Immunocompromised Swiss Cohorts Based Trial Platform

Who this might be right for
Immunocompromised Patients
University Hospital, Basel, Switzerland 610
Testing effectiveness (Phase 2)Study completedNCT05683834
What this trial is testing

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Who this might be right for
Epstein-Barr Virus InfectionInfectious MononucleosisHerpesvirus
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableUnknownNCT04679428
What this trial is testing

Immunological Characteristics of COVID-19 Patients

Who this might be right for
Covid19
The University Clinic of Pulmonary and Allergic Diseases Golnik 230
Next Page